PEGylation as a strategy for improving nanoparticle-based drug and gene delivery Adv Drug Deliv Rev . 2016 Apr 199(Pt A) 28-51. doi 10.1016/j.addr.2015.09.012.
97 days Advanced Drug Delivery Reviews. Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic. 105 days Advanced Drug Delivery Reviews. Robust and smart polypeptide-based nanomedicines for targeted tumor therapy.
2021-7-16 · " Recent trends in protein and peptide-based biomaterials for advanced drug delivery. " Adv Drug Deliv Rev vol. 156 pp. 133-187 2020. A. K. Varanko and Chilkoti A. " Molecular and Materials Engineering for Delivery of Peptide Drugs to Treat Type 2 Diabetes.
2021-6-8 · Adv Drug Deliv Rev . 2021521 Adv Drug Deliv Rev"Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases" . RNA
2019-10-21 · AUTHORS PREPRINT of Adv Drug Deliv Rev. doi 10.1016/j.addr.2017.10.008 . Insights into the key roles of epigenetics in matrix macromolecules-associated wound healing . Zoi Piperigkou a Martin Götte b Achilleas D. Theocharis a and Nikos K. Karamanos a
2014-8-27 · 1. Adv Drug Deliv Rev. 2016 Apr 199(Pt A) 113-128. doi 10.1016/j.addr.2015.05.009. Epub 2015 May 22. Progress and problems with the use of suicide genes for targeted cancer therapy. Karjoo Z(1) Chen X(1) Hatefi A(2). Author information (1)Department of Pharmaceutics Rutgers The State University of New Jersey Piscataway NJ 08855 United
Advanced Drug Delivery Reviews Journal ScienceDirect by Elsevier. Advanced Drug Delivery Reviews. 24.7 CiteScore. 15.470 Impact Factor. Articles Issues. About. Publish. Menu. Articles
2021-7-4 · ADV DRUG DELIVER REV SCI " ADV DRUG DELIVER REV " " ADV DRUG DELIVER REV "
Adv.Drug Deliv.Rev. 46(1-3) 3-26 March 2001. has been cited by the following article Article. It Is Important to Compute Intramolecular Hydrogen Bonding in Drug Design María J. R. Yunta 1 1 Departamento de Química Orgánica I Facultad de Química Universidad Complutense Madrid Spain.
37. Egan WJ Lauri G. Prediction of intestinal permeability. Adv Drug Deliv Rev 2002 54 273–289. 38. Lipinski CA Lombardo F Dominy BW et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and devel-opment settings. Adv Drug Deliv Rev
2006-5-20 · 1. Adv Drug Deliv Rev. 2006 May 2058(2) 128-49. Epub 2006 Mar 6. Osteoarthritis pathobiology-targets and ways for therapeutic intervention. Aigner T(1) Sachse A Gebhard PM Roach HI. Author information (1)Institute of Pathology University of Leipzig Liebigstrasse 26 04103 Leipzig Germany. thomas.aigner medizin.uni-leipzig
2021-2-7 · Advanced drug delivery reviews (ISSN 0169-409X 1872-8294) Table of Contents. From Advanced drug delivery reviews. 2021 -
2020-12-15 · Adv Drug Deliv Rev. Author manuscript available in PMC 2011 September 13. Author manuscript available in PMC 2011 September 13. Published in final edited form as
37. Egan WJ Lauri G. Prediction of intestinal permeability. Adv Drug Deliv Rev 2002 54 273–289. 38. Lipinski CA Lombardo F Dominy BW et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and devel-opment settings. Adv Drug Deliv Rev
2021-2-26 · Adv. Drug Deliv. Rev. 2020 160 199-211. 2021-02-26. Robust and smart polypeptide-based nanomedicines for targeted tumor therapy. Nanomedicines based on synthetic polypeptides are among the most versatile and advanced platforms for tumor therapy. Notably several polypeptide-based nanodrugs are currently under human clinical assessments.
2021-7-4 · ADV DRUG DELIVER REV SCI " ADV DRUG DELIVER REV " " ADV DRUG DELIVER REV "
2018-2-22 · Targeted drug delivery aims to increase the therapeutic index by making more drug molecules available at the diseased sites while reducing systemic drug exposure. In this update we provide an overview of polymer-drug conjugates that have advanced into the clinical trials. These systems use synthetic water-soluble polymers as the drug carriers.
1. Adv Drug Deliv Rev. 2013 Oct65(10) 1299-315. doi 10.1016/j.addr.2012.11.007. Epub 2013 Jan 28. Curb challenges of the "Trojan Horse" approach smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery.
Adv Drug Deliv Rev. 2005 Dec 1457(15) 2106-29. doi 10.1016/j.addr.2005.09.018. Epub 2005 Nov 21.
2021-2-26 · Adv. Drug Deliv. Rev. 2020 160 199-211. 2021-02-26. Robust and smart polypeptide-based nanomedicines for targeted tumor therapy. Nanomedicines based on synthetic polypeptides are among the most versatile and advanced platforms for tumor therapy. Notably several polypeptide-based nanodrugs are currently under human clinical assessments.
2001-12-31 · Abstract. Environmentally sensitive hydrogels have enormous potential in various applications. Some environmental variables such as low pH and elevated temperatures are found in the body. For this reason either pH-sensitive and/or temperature-sensitive hydrogels can be used for site-specific controlled drug delivery.
2020-12-30 · Adv Drug Deliv Rev 49 1-2 (2001). 3. Kakizawa Y. Kataoka K. Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev 54 203-22 (2002). 4. Torchilin V. P. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv Drug Deliv Rev 54 235-52 (2002). 5.
2020-12-15 · Adv Drug Deliv Rev. Author manuscript available in PMC 2011 September 13. Author manuscript available in PMC 2011 September 13. Published in final edited form as
Adv. Drug Deliv. Rev. 74 (-) 115-121 2014-07-00 online 2013-08-31 Affiliated researcher SciLifeLab Data Centre Version 4.1.0
2021-2-7 · Advanced drug delivery reviews (ISSN 0169-409X 1872-8294) Table of Contents. From Advanced drug delivery reviews. 2021 -
2018-2-22 · Adv Drug Deliv Rev. 2008 May 22 60(8) 886–898. NIH-PA Author Manuscript. that active targeting could be achieved if a homing moiety was introduced to the same polymeric carrier (Fig. 1). Since then polymer-drug conjugates have become a fast-growing
2021-2-7 · Advanced drug delivery reviews (ISSN 0169-409X 1872-8294) Table of Contents. From Advanced drug delivery reviews. 2021 -
1997-1-15 · Experimental and computational approaches to estimate solubility and permeability in discovery and development settings are described. In the discovery setting the rule of 5 predicts that poor absorption or permeation is more likely when there are more than 5 H bond donors 10 H bond acceptors the molecular weight (MWT) is greater than 500 and the calculated Log P (CLogP) is
T2Adv Drug Deliv Rev. AUPouton C. W. AUSeymour L. W. N1M11 Pouton Seymour ENG 2000/06/06 Adv Drug Deliv Rev. 1998 Oct 534(1) 3-19. PY1998. Y11998. N2The future of non-viral gene therapy depends on a detailed understanding of the barriers to delivery of polynucleotides.
Adv Drug Deliv Rev. 2018 May130 17-38. doi 10.1016/j.addr.2018.07.007. Epub 2018 Jul 19.
2014-8-27 · 1. Adv Drug Deliv Rev. 2016 Apr 199(Pt A) 113-128. doi 10.1016/j.addr.2015.05.009. Epub 2015 May 22. Progress and problems with the use of suicide genes for targeted cancer therapy. Karjoo Z(1) Chen X(1) Hatefi A(2). Author information (1)Department of Pharmaceutics Rutgers The State University of New Jersey Piscataway NJ 08855 United
2021-6-8 · Adv Drug Deliv Rev . 2021521 Adv Drug Deliv Rev"Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases" . RNA
Journal Abbreviation ADV DRUG DELIVER REV Journal ISSN 0169-409X. About Advanced Drug Delivery Reviews. The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope covering the key issues for effective
2021-6-8 · Adv Drug Deliv Rev . 2021521 Adv Drug Deliv Rev"Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases" . RNA
2021-7-4 · ADV DRUG DELIVER REV SCI " ADV DRUG DELIVER REV " " ADV DRUG DELIVER REV "
2021-6-8 · Adv Drug Deliv Rev"Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases"
2021-6-8 · Adv Drug Deliv Rev . 2021521 Adv Drug Deliv Rev"Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases" . RNA
2021-2-26 · Adv. Drug Deliv. Rev. 2020 160 199-211. 2021-02-26. Robust and smart polypeptide-based nanomedicines for targeted tumor therapy. Nanomedicines based on synthetic polypeptides are among the most versatile and advanced platforms for tumor therapy.
2021-6-8 · Adv Drug Deliv Rev 2021-06-08 10 14 2021521 Adv Drug Deliv Rev"Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases"
Journal Abbreviation ADV DRUG DELIVER REV Journal ISSN 0169-409X. About Advanced Drug Delivery Reviews. The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope covering the key issues for effective
BQ+ Medical not only produce components for manufacturers all over the world, but also provide private label manufacturing for leading brand distributors in different countries.
8,Cheye Road,Songjiang District,Shanghai 201611 China.
Tel: 86-021-57743953
Email: [email protected]
Copyright © BQ PLUS MEDICAL CO., LTDSitemap | Contact Us |
